Follow-up Trial to Evaluate Long-term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Clinical trial NCT00175916 · COMPLETED
Trial details
- NCT number
- NCT00175916
- Sponsor
- UCB Pharma
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-09-01
- Primary completion
- 2019-05-01
- Enrollment
- 853
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.